US Stock MarketDetailed Quotes

GRTX Galera Therapeutics

Watchlist
  • 0.176
  • +0.001+0.51%
Trading May 15 10:30 ET
9.57MMarket Cap-132P/E (TTM)

Galera Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-3.27%-44.85M
28.90%-9.92M
-35.95%-12.52M
-20.93%-10.75M
-2.47%-11.67M
36.10%-43.43M
20.07%-13.95M
49.96%-9.21M
47.12%-8.89M
25.60%-11.39M
Net income from continuing operations
5.05%-59.08M
65.49%-5.59M
5.99%-15.07M
-42.27%-20.71M
-14.68%-17.71M
22.74%-62.22M
3.68%-16.19M
29.14%-16.03M
34.97%-14.56M
17.48%-15.44M
Operating gains losses
---72K
--0
--0
----
----
----
----
----
----
----
Depreciation and amortization
127.19%259K
726.92%215K
-55.56%12K
-60.00%12K
-35.48%20K
-85.35%114K
-94.40%26K
-74.53%27K
-70.59%30K
-70.75%31K
Deferred tax
--0
----
----
----
----
---70K
----
----
----
----
Other non cash items
-1.36%11.41M
-78.79%705K
-35.69%2.09M
62.99%4.4M
83.37%4.22M
60.84%11.57M
43.77%3.32M
39.45%3.25M
107.30%2.7M
83.80%2.3M
Change In working capital
-17,317.65%-2.93M
-132.06%-6.44M
-152.03%-937K
268.55%4.1M
376.61%343K
100.65%17K
48.40%-2.77M
2,323.46%1.8M
-56.63%1.11M
-147.33%-124K
-Change in receivables
200.00%3.24M
--0
--0
----
----
---3.24M
---3.24M
--0
----
----
-Change in prepaid assets
-79.68%514K
60.01%-619K
-66.30%365K
-71.95%322K
-75.84%446K
347.46%2.53M
29.41%-1.55M
26.67%1.08M
-39.07%1.15M
217.73%1.85M
-Change in payables and accrued expense
-1,393.47%-8.51M
-523.57%-7.68M
-240.20%-994K
94.02%227K
96.52%-69K
162.55%658K
169.13%1.81M
159.93%709K
-87.32%117K
-208.26%-1.98M
-Change in other current assets
485.45%1.93M
601.85%1.9M
-477.78%-272K
432.22%299K
-87.18%10K
234.15%330K
206.72%270K
-70.85%72K
63.11%-90K
1,850.00%78K
-Change in other current liabilities
59.69%-104K
44.62%-36K
42.86%-36K
119.35%12K
35.29%-44K
15.96%-258K
78.83%-65K
---63K
-2,166.67%-62K
-2,166.67%-68K
Cash from discontinued investing activities
Operating cash flow
-3.27%-44.85M
28.90%-9.92M
-35.95%-12.52M
-20.93%-10.75M
-2.47%-11.67M
36.10%-43.43M
20.07%-13.95M
49.96%-9.21M
47.12%-8.89M
25.60%-11.39M
Investing cash flow
Cash flow from continuing investing activities
13.75%27.29M
43.04%3.98M
127.28%10.46M
14.12%7.55M
-46.93%5.31M
358.08%23.99M
-85.86%2.78M
110.70%4.6M
-57.99%6.62M
-22.41%10M
Net PPE purchase and sale
-136.00%-59K
---9K
--0
-614.29%-50K
--0
91.17%-25K
--0
80.00%-5K
63.16%-7K
93.01%-13K
Net investment purchase and sale
13.88%27.35M
43.36%3.98M
127.03%10.46M
14.75%7.6M
-47.00%5.31M
335.05%24.02M
-85.90%2.78M
110.71%4.61M
-57.99%6.62M
-23.41%10.01M
Cash from discontinued investing activities
Investing cash flow
13.75%27.29M
43.04%3.98M
127.28%10.46M
14.12%7.55M
-46.93%5.31M
358.08%23.99M
-85.86%2.78M
110.70%4.6M
-57.99%6.62M
-22.41%10M
Financing cash flow
Cash flow from continuing financing activities
709.87%31.5M
-108.59%-232K
21,240.00%2.13M
90,500.00%1.81M
2,264.43%27.78M
-94.17%3.89M
12,181.82%2.7M
-99.98%10K
-99.99%2K
400.00%1.18M
Net common stock issuance
669.41%29.3M
-108.62%-232K
--1.93M
--0
2,370.73%27.6M
-52.05%3.81M
134,450.00%2.69M
--0
--0
--1.12M
Proceeds from stock option exercised by employees
2,612.35%2.2M
--0
1,910.00%201K
90,500.00%1.81M
217.24%184K
-93.60%81K
-45.00%11K
-98.88%10K
-98.33%2K
-75.32%58K
Cash from discontinued financing activities
Financing cash flow
709.87%31.5M
-108.59%-232K
21,240.00%2.13M
90,500.00%1.81M
2,264.43%27.78M
-94.17%3.89M
12,181.82%2.7M
-99.98%10K
-99.99%2K
400.00%1.18M
Net cash flow
Beginning cash position
-78.27%4.32M
91.15%24.43M
40.15%24.35M
31.01%25.74M
-78.27%4.32M
25.12%19.86M
-27.52%12.78M
-54.83%17.38M
43.53%19.65M
25.12%19.86M
Current changes in cash
189.69%13.94M
27.08%-6.17M
101.68%77K
38.96%-1.39M
10,109.81%21.42M
-489.84%-15.54M
-480.06%-8.46M
77.94%-4.6M
-109.16%-2.27M
90.21%-214K
End cash Position
323.01%18.26M
323.01%18.26M
91.15%24.43M
40.15%24.35M
31.01%25.74M
-78.27%4.32M
-78.27%4.32M
-27.52%12.78M
-54.83%17.38M
43.53%19.65M
Free cash flow
-3.35%-44.91M
28.83%-9.92M
-35.88%-12.52M
-21.40%-10.8M
-2.35%-11.67M
36.33%-43.45M
20.31%-13.95M
50.00%-9.22M
47.14%-8.89M
26.41%-11.4M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -3.27%-44.85M28.90%-9.92M-35.95%-12.52M-20.93%-10.75M-2.47%-11.67M36.10%-43.43M20.07%-13.95M49.96%-9.21M47.12%-8.89M25.60%-11.39M
Net income from continuing operations 5.05%-59.08M65.49%-5.59M5.99%-15.07M-42.27%-20.71M-14.68%-17.71M22.74%-62.22M3.68%-16.19M29.14%-16.03M34.97%-14.56M17.48%-15.44M
Operating gains losses ---72K--0--0----------------------------
Depreciation and amortization 127.19%259K726.92%215K-55.56%12K-60.00%12K-35.48%20K-85.35%114K-94.40%26K-74.53%27K-70.59%30K-70.75%31K
Deferred tax --0-------------------70K----------------
Other non cash items -1.36%11.41M-78.79%705K-35.69%2.09M62.99%4.4M83.37%4.22M60.84%11.57M43.77%3.32M39.45%3.25M107.30%2.7M83.80%2.3M
Change In working capital -17,317.65%-2.93M-132.06%-6.44M-152.03%-937K268.55%4.1M376.61%343K100.65%17K48.40%-2.77M2,323.46%1.8M-56.63%1.11M-147.33%-124K
-Change in receivables 200.00%3.24M--0--0-----------3.24M---3.24M--0--------
-Change in prepaid assets -79.68%514K60.01%-619K-66.30%365K-71.95%322K-75.84%446K347.46%2.53M29.41%-1.55M26.67%1.08M-39.07%1.15M217.73%1.85M
-Change in payables and accrued expense -1,393.47%-8.51M-523.57%-7.68M-240.20%-994K94.02%227K96.52%-69K162.55%658K169.13%1.81M159.93%709K-87.32%117K-208.26%-1.98M
-Change in other current assets 485.45%1.93M601.85%1.9M-477.78%-272K432.22%299K-87.18%10K234.15%330K206.72%270K-70.85%72K63.11%-90K1,850.00%78K
-Change in other current liabilities 59.69%-104K44.62%-36K42.86%-36K119.35%12K35.29%-44K15.96%-258K78.83%-65K---63K-2,166.67%-62K-2,166.67%-68K
Cash from discontinued investing activities
Operating cash flow -3.27%-44.85M28.90%-9.92M-35.95%-12.52M-20.93%-10.75M-2.47%-11.67M36.10%-43.43M20.07%-13.95M49.96%-9.21M47.12%-8.89M25.60%-11.39M
Investing cash flow
Cash flow from continuing investing activities 13.75%27.29M43.04%3.98M127.28%10.46M14.12%7.55M-46.93%5.31M358.08%23.99M-85.86%2.78M110.70%4.6M-57.99%6.62M-22.41%10M
Net PPE purchase and sale -136.00%-59K---9K--0-614.29%-50K--091.17%-25K--080.00%-5K63.16%-7K93.01%-13K
Net investment purchase and sale 13.88%27.35M43.36%3.98M127.03%10.46M14.75%7.6M-47.00%5.31M335.05%24.02M-85.90%2.78M110.71%4.61M-57.99%6.62M-23.41%10.01M
Cash from discontinued investing activities
Investing cash flow 13.75%27.29M43.04%3.98M127.28%10.46M14.12%7.55M-46.93%5.31M358.08%23.99M-85.86%2.78M110.70%4.6M-57.99%6.62M-22.41%10M
Financing cash flow
Cash flow from continuing financing activities 709.87%31.5M-108.59%-232K21,240.00%2.13M90,500.00%1.81M2,264.43%27.78M-94.17%3.89M12,181.82%2.7M-99.98%10K-99.99%2K400.00%1.18M
Net common stock issuance 669.41%29.3M-108.62%-232K--1.93M--02,370.73%27.6M-52.05%3.81M134,450.00%2.69M--0--0--1.12M
Proceeds from stock option exercised by employees 2,612.35%2.2M--01,910.00%201K90,500.00%1.81M217.24%184K-93.60%81K-45.00%11K-98.88%10K-98.33%2K-75.32%58K
Cash from discontinued financing activities
Financing cash flow 709.87%31.5M-108.59%-232K21,240.00%2.13M90,500.00%1.81M2,264.43%27.78M-94.17%3.89M12,181.82%2.7M-99.98%10K-99.99%2K400.00%1.18M
Net cash flow
Beginning cash position -78.27%4.32M91.15%24.43M40.15%24.35M31.01%25.74M-78.27%4.32M25.12%19.86M-27.52%12.78M-54.83%17.38M43.53%19.65M25.12%19.86M
Current changes in cash 189.69%13.94M27.08%-6.17M101.68%77K38.96%-1.39M10,109.81%21.42M-489.84%-15.54M-480.06%-8.46M77.94%-4.6M-109.16%-2.27M90.21%-214K
End cash Position 323.01%18.26M323.01%18.26M91.15%24.43M40.15%24.35M31.01%25.74M-78.27%4.32M-78.27%4.32M-27.52%12.78M-54.83%17.38M43.53%19.65M
Free cash flow -3.35%-44.91M28.83%-9.92M-35.88%-12.52M-21.40%-10.8M-2.35%-11.67M36.33%-43.45M20.31%-13.95M50.00%-9.22M47.14%-8.89M26.41%-11.4M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg